Statewide legal status
Minnesota lists psilocybin and psilocyn as Schedule I controlled substances. Personal possession is not authorized statewide.

MN legal and access quick reference
Reviewed on September 29, 2026 by iMD teamA concise, source-dated explanation of statewide law, regulated access, and the difference between state and local policy.
Laws and implementation can change quickly. This page is educational information, not legal advice.
Minnesota lists psilocybin and psilocyn as Schedule I controlled substances. Personal possession is not authorized statewide.
Minnesota has no current statewide psilocybin service-center, personal-use, dispensary, or retail program.
Minnesota enacted a 2026 requirement directing the Office of Cannabis Management to develop recommendations for a supervised psilocybin therapeutic-use program for adults 21 and older with qualifying medical conditions. The report is due January 15, 2027; this planning mandate does not itself create a current access program.
Minnesota Laws 2026, Chapter 123, Section 116 requires the Office of Cannabis Management to publish recommendations by January 15, 2027 for administering a psilocybin therapeutic-use program. The contemplated model is for adults age 21 and older with qualifying medical conditions to access and use psilocybin under facilitator supervision at a treatment facility.
The report must assess program feasibility, approaches for defining and updating qualifying medical conditions, and recommendations for program development and administration. It must be informed by the Minnesota Psychedelic Medicine Task Force’s January 2025 legislative report. The law also directs the office to regularly analyze federal funding opportunities that could support a future supervised program.
Minnesota has documented municipal actions in Minneapolis. Those actions affect local priorities only; they do not create statewide legalization, licensed retail, or medical suitability.
The statewide explanation above covers Duluth, Minneapolis, Rochester and Saint Paul. A separate page appears below only where a documented municipal action adds material local context.
This review prioritizes Minnesota statutes, enacted 2026 law, the Minnesota Department of Health task-force record, and the Legislative Reference Library’s official mandate record.
Minnesota lists psilocybin and psilocyn as Schedule I controlled substances. Personal possession is not authorized statewide. Minnesota has no current statewide psilocybin service-center, personal-use, dispensary, or retail program.
Minnesota has no current statewide psilocybin service-center, personal-use, dispensary, or retail program. The task-force recommendations and required feasibility report are planning steps, not an active access program.
No. Minneapolis’s executive order affects city enforcement priorities only. It does not legalize commercial sale, create statewide access, or override Minnesota or federal law.
Minnesota enacted Chapter 123, Section 116, requiring the Office of Cannabis Management to recommend how a supervised psilocybin therapeutic-use program could be administered for adults 21 and older with qualifying medical conditions. The report is due January 15, 2027. The mandate is a planning step and does not itself establish current public access.
The product-site link provides product-format and business-policy information. It does not change the law described on this page or establish legal access in any jurisdiction.